Registry of Aortic Valve Bioprostheses Established by Catheter
Recruiting
Observational Study
Transcatheter Aortic Valve Implantation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- French Cardiology Society · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this registry is to evaluate the overall survival up to 10 years of patients with aortic valve bioprostheses implanted via the transarterial or transapical route. Data from the register is enhanced by matching it with continuous data in the SNDS.
Mandated by the French health authorities, this registry must be maintained as part of the management of any patient undergoing transarterial…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: Patients who have undergone transarterial or transapical aortic valve bioprosthesis implantation
Exclusion Criteria: Patient has not given consent
Contacts